Nexvet Biopharma (NVET) Provides Additional NV-01 Data at Investor Day; Cowen Reiterates Outperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. SPY
3. GLOB
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Nexvet Biopharma (NVET) Provides Additional NV-01 Data at Investor Day; Cowen Reiterates Outperform

Nexvet Biopharma (NVET) Presents NV-01 at Symposium; Piper Jaffray Reiterates Overweight

November 24, 2015 7:34 AM EST

Piper Jaffray maintained an Overweight rating on Nexvet Biopharma (NASDAQ: NVET), and cut the price target to $13.00 (from $17.00), after attending the company's Animal Health Symposium. The company provided more details on the positive pivotal study results for NV-01. The presentation also lead Piper Jaffray to believe that there is demand for... More